This trial is conducted in Europe. The aim of this clinical trial is to evaluate the height gain during 12 months of growth hormone treatment in children born small for gestational age due to intrauterine growth retardation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
160
Height gain according to birth group, age of onset, the treatment and Tanner stage
Time frame: during 12 months of treatment
Height SDS for bone age
Time frame: during 12 months of treatment
Height velocity SDS for bone age
Time frame: during 12 months of treatment
Height velocity for chronological age
Time frame: during 12 months of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Novo Nordisk Investigational Site
Albacete, Spain
Novo Nordisk Investigational Site
Alicante, Spain
Novo Nordisk Investigational Site
Almería, Spain
Novo Nordisk Investigational Site
Badajoz, Spain
Novo Nordisk Investigational Site
Badalona, Spain
Novo Nordisk Investigational Site
Barcelona, Spain
Novo Nordisk Investigational Site
Barcelona, Spain
Novo Nordisk Investigational Site
Calella de La Costa, Spain
Novo Nordisk Investigational Site
Cáceres, Spain
Novo Nordisk Investigational Site
Córdoba, Spain
...and 27 more locations